A new kind of cellular immunotherapy shows promise in preventing Alzheimer's-associated plaques from forming in the brain – ...

Neuroscientists at King’s College London (UK) have pinpointed a mechanism behind the increased neural connectivity seen in very early stages of Alzheimer’s disease. Published in Translational ...

A new King’s College London study finds a cancer drug may reverse brain connectivity changes linked to early Alzheimer’s ...

A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering mechanism of action for the treatment of Alzheimer's disease. Unlike ...

A new study suggests Alzheimer’s disease may be detectable through subtle shape changes in proteins found in the blood.

The new generation of Alzheimer's disease drugs—the first proven to change the course of the disease—typically extend ...

A caregiver can help a person with ATTR-CM build a care team of healthcare professionals to manage symptoms, guide treatment ...

Researchers developed a blood test that analyzes structural changes in three proteins linked to Alzheimer’s progression. Protein folding patterns distinguished healthy individuals, mild cognitive ...

New research demonstrates that preclinical cognitive decline may be identifiable through subtle language shifts. An analysis of Terry Pratchett's literature revealed significant decreases in adjective ...

Scientists at Rice University have produced the first full, dye-free molecular atlas of an Alzheimer’s brain. By combining ...

In people destined to get Alzheimer's in their mid-40s, one protein can delay the onset of the disease by about 20 years.

Early Alzheimer’s marker, phosphorylated tau protein (pTau), doesn’t just stay in the brain. Its presence in the heart and kidneys could transform diagnostics.